1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Category Archives: Monoclonal Anti-CD20 Antibodies

03Dec/12

Record Number of Bendamustine Abstracts Accepted for Presentation at the … – SYS-CON Media (press release)

December 3, 2012Monoclonal Anti-CD20 Antibodiesadmin

Record Number of Bendamustine Abstracts Accepted for Presentation at the …SYS-CON Media (press release)Two oral and three poster presentations focus on indolent NHL (iNHL) and MCL, comparing treatment with bendamustine-rituximab (B-R) to the standard…

03Dec/12

Record Number of Bendamustine Abstracts Accepted for Presentation at the … – PR Newswire UK (press release)

December 3, 2012Monoclonal Anti-CD20 Antibodiesadmin

Record Number of Bendamustine Abstracts Accepted for Presentation at the …PR Newswire UK (press release)Two oral and three poster presentations focus on indolent NHL (iNHL) and MCL, comparing treatment with bendamustine-rituximab (B-R) to the standar…

30Nov/12

Latest topics referred to NICE: October 2012 – dh.gov.uk

November 30, 2012Monoclonal Anti-CD20 Antibodiesadmin

Latest topics referred to NICE: October 2012dh.gov.ukTo appraise the clinical and cost effectiveness of rituximab in combination with corticosteroids within its licensed indication for the treatment of anti-neutrophil cytoplasmic antibody-associated va…

28Nov/12

Scientists at Technion-Israel Institute of Technology Release New Data on … – Equities.com

November 28, 2012Monoclonal Anti-CD20 Antibodiesadmin

Scientists at Technion-Israel Institute of Technology Release New Data on …Equities.comOur news editors obtained a quote from the research from the Technion-Israel Institute of Technology, "Here, we utilize gold nanospheres conjugated to Rituxim…

28Nov/12

Chugai in co-development accord for obinutuzumab with Nippon Shinyaku – The Pharma Letter

November 28, 2012Monoclonal Anti-CD20 Antibodiesadmin

Chugai in co-development accord for obinutuzumab with Nippon ShinyakuThe Pharma LetterGA101 is a glycoengineered type II anti-CD20 monoclonal antibody created by GlycArt AG and is a compound that selectively targets the CD20 protein on B-cells, the sam…

27Nov/12

NIPPON SHINYAKU CO. LTD. : Co-Development and Co-Marketing Agreement … – 4-traders

November 27, 2012Monoclonal Anti-CD20 Antibodiesadmin

NIPPON SHINYAKU CO. LTD. : Co-Development and Co-Marketing Agreement …4-tradersGA101 is a glycoengineered type II anti-CD20 monoclonal antibody created by GlycArt AG and is a compound that selectively targets the CD20 protein on B-cells, same as ritu…

27Nov/12

CHUGAI PHARMACEUTICAL CO., LTD. : Co-Development and Co-Marketing … – 4-traders

November 27, 2012Monoclonal Anti-CD20 Antibodiesadmin

CHUGAI PHARMACEUTICAL CO., LTD. : Co-Development and Co-Marketing …4-tradersGA101 is a glycoengineeredtype II anti-CD20 monoclonal antibody created by GlycArt AG and is a compound that selectively targets the CD20 protein on B-cells, same as rituxima…

21Nov/12

Liposomal doxorubicin inferior for AIDS-related lymphoma – ModernMedicine

November 21, 2012Monoclonal Anti-CD20 Antibodiesadmin

Liposomal doxorubicin inferior for AIDS-related lymphomaModernMedicine"I think it's fair to say the regimen was not as effective as we hoped it would be, and it's probably not as effective as R-EPOCH," that is, etoposide, prednisone, …

21Nov/12

Rituximab may help patients with aPL-related clinical problems – News-Medical.net

November 21, 2012Monoclonal Anti-CD20 Antibodiesadmin

Rituximab may help patients with aPL-related clinical problemsNews-Medical.netRituximab, a drug used to treat cancer and arthritis, may help patients with antiphospholipid antibodies (aPLs) who suffer from aPL-related clinical problems that do not resp…

20Nov/12

Rituximab shows promise for clinical problems tied to antiphospholipid antibodies – Science Codex

November 20, 2012Monoclonal Anti-CD20 Antibodiesadmin

Rituximab shows promise for clinical problems tied to antiphospholipid antibodiesScience CodexRituximab, a drug used to treat cancer and arthritis, may help patients with antiphospholipid antibodies (aPLs) who suffer from aPL-related clinical problems …

Posts navigation

  • « Previous
  • 1
  • …
  • 93
  • 94
  • 95
  • 96
  • 97
  • …
  • 145
  • Next »

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos